Overview of the risk factors, prevention and management of SARS-COV-2
This thesis report is submitted in partial fulfillment of the requirement for the degree of Master of Science in Biotechnology, 2020.
Autore principale: | Mustafa, Nashrah |
---|---|
Altri autori: | Hossain, Mahboob |
Natura: | Tesi |
Lingua: | en_US |
Pubblicazione: |
Brac University
2021
|
Soggetti: | |
Accesso online: | http://hdl.handle.net/10361/14501 |
Documenti analoghi
-
In-silico based vaccine development: targeting nucleocapsid protein of SARS-CoV-2.
di: Iva, Yesmine Akter
Pubblicazione: (2022) -
Detection of genetic diversity of SARS-CoV-2 in wastewater to monitor COVID-19 transmission
di: Sarwar, Subyeta Binte
Pubblicazione: (2024) -
An in silico Method to developing an epitope-based peptide vaccination against SARS-CoV-2's Envelope Protein (E)
di: Intesar, Mohammad Nafees
Pubblicazione: (2023) -
Omicron, delta, and beta, deadliest among SARS-CoV-2 variants: an in silico analysis
di: Bosu, Sagar
Pubblicazione: (2023) -
Wave-wise comparison of COVID 19 based on SARS-CoV-2 Variants of Concern (VOCs) in Bangladesh, India, Sri Lanka, Pakistan, Nepal and the probable reasons behind the less devastating effects of Delta variant in Bangladesh: a review
di: Hasan, Mahfuzul, et al.
Pubblicazione: (2022)